| Reference(英) |
|
3716
Onuki K1, Sugiyama H, Ishige K, Kawamoto T, Ota T, Ariizumi S, Yamato M, Kadota S, Takeuchi K, Ishikawa A, Onodera M, Onizawa K, Yamamoto M, Miyoshi E, Shoda J.
Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
J Gastroenterol
2014
49(4):702-14
PubMed ID: 23588887
DOI: 10.1007/s00535-013-0813-2
|
|
2323
Kawashima R, Abei M, Fukuda K, Nakamura K, Murata T, Wakayama M, Seo E, Hasegawa N, Mizuguchi H, Obata Y, Hyodo I, Hamada H, Yokoyama KK.
EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus
Int J Cancer
2011
129(5):1244-53
PubMed ID: 21710497
DOI: 10.1002/ijc.25758
|
|
3708
Ishige K, Shoda J, Kawamoto T, Matsuda S, Ueda T, Hyodo I, Ohkohchi N, Puri RK, Kawakami K.
Potent in vitro and in vivo antitumor activity of interleukin-4-conjugated Pseudomonas exotoxin against human biliary tract carcinoma.
Int J Cancer
2008
123(12):2915-22
PubMed ID: 18798553
DOI: 10.1002/ijc.23865
|
|
2317
Hori H, Ajiki T, Mita Y, Horiuchi H, Hirata K, Matsumoto T, Morimoto H, Fujita T, Ku Y, Kuroda Y.
Frequent activation of mitogen-activated protein kinase relative to Akt in extrahepatic biliary tract cancer
J Gastroenterol
2007
42(7):567-72
PubMed ID: 17653653
DOI: 10.1007/s00535-007-2055-7
|
|
2324
Wakayama M, Abei M, Kawashima R, Seo E, Fukuda K, Ugai H, Murata T, Tanaka N, Hyodo I, Hamada H, Yokoyama KK.
E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers
Clin Cancer Res
2007
13(10):3043-50
PubMed ID: 17505007
DOI: 10.1158/1078-0432.CCR-06-2103
|
|
2673
Ghosh, Mila, Koike, Naoto, Yanagimoto, Go, Tsunoda, Shin-Ichi, Kaul, Sunil, Hirano, Takashi, Emura, Fabian, Kashiwagi, Hironobu, Kawamoto, Toru, Ohkohchi, Nobuhiro, Saijo, Kaoru, Ohno, Tadao, Miwa, Masanao, Todoroki, Takeshi
Establishment and characterization of unique human gallbladder cancer cell lines.
Int J Oncol
2004
24:1189-96
PubMed ID: 15067341
|
|
3707
Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T.
Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
Clin Cancer Res
2004
10(6):2090-9
PubMed ID: 15041730
DOI: 10.1158/1078-0432.ccr-1024-03
|
|
2322
Shoda J, Ueda T, Kawamoto T, Todoroki T, Asano T, Sugimoto Y, Ichikawa A, Maruyama T, Nimura Y, Tanaka N.
Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis
Clin Gastroenterol Hepatol
2003
1(4):285-96
PubMed ID: 15017670
|
|
3697
Takada M, Ku Y, Habara K, Ajiki T, Suzuki Y, Kuroda Y.
Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells.
World J Surg
2002
26(6):683-6
PubMed ID: 12053219
DOI: 10.1007/s00268-001-0290-2
|
|
2237
Moon,Y., Dahlberg,W. K., Yu,Y., Ohno,T. Todoroki,T., and Little,J. B.
Radiosensitivity of human biliary tract cancer cell lines in vitro
Int J Oncol
1997
10:545-551
PubMed ID: 21533411
DOI: 10.3892/ijo.10.3.545
|
| 利用者成果(英) |
|
21193
Na L, Masuda S, Nagao S, Morisaki S, Iwamoto N, Sakanashi K, Onishi H.
C4orf47 Contributes to the Induction of Stem-like Properties in Gallbladder Cancer Under Hypoxia.
Anticancer Res
2023
43(5):1925-1932
PubMed ID: 37097647
DOI: 10.21873/anticanres.16352
|
|
20194
Ueta E, Tsutsumi K, Kato H, Matsushita H, Shiraha H, Fujii M, Matsumoto K, Horiguchi S, Okada H.
Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients.
Sci Rep
2021
11(1):12298
PubMed ID: 34112884
DOI: 10.1038/s41598-021-91804-0
|
|
16869
Ichimiya S, Onishi H, Nagao S, Koga S, Sakihama K, Nakayama K, Fujimura A, Oyama Y, Imaizumi A, Oda Y, Nakamura M.
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer
Oncol Rep
2021
45(3):997-1010
PubMed ID: 33650666
DOI: 10.3892/or.2021.7947
|
|
12106
García P, Rosa L, Vargas S, Weber H, Espinoza JA, Suárez F, Romero-Calvo I, Elgueta N, Rivera V, Nervi B, Obreque J, Leal P, Viñuela E, Aguayo G, Muñiz S, Sagredo A, Roa JC, Bizama C.
Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer.
Cancers (Basel)
2020
PubMed ID: 32218280
DOI: 10.3390/cancers12040778
|
|
12131
García P, Bizama C, Rosa L, Espinoza JA, Weber H, Cerda-Infante J, Sánchez M, Montecinos VP, Lorenzo-Bermejo J, Boekstegers F, Dávila-López M, Alfaro F, Leiva-Acevedo C, Parra Z, Romero D, Kato S, Leal P, Lagos M, Roa JC.
Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
Biol. Res.
2020
PubMed ID: 32293552
DOI: 10.1186/s40659-020-00282-7
|
|
13185
Pandey A, Stawiski EW, Durinck S, Gowda H, Goldstein LD, Barbhuiya MA, Schröder MS, Sreenivasamurthy SK, Kim SW, Phalke S, Suryamohan K, Lee K, Chakraborty P, Kode V, Shi X, Chatterjee A, Datta K, Khan AA, Subbannayya T, Wang J, Chaudhuri S, Gupta S, Shrivastav BR, Jaiswal BS, Poojary SS, Bhunia S, Garcia P, Bizama C, Rosa L, Kwon W, Kim H, Han Y, Yadav TD, Ramprasad VL, Chaudhuri A, Modrusan Z, Roa JC, Tiwari PK, Jang JY, Seshagiri S.
Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate.
Nat Commun
2020
PubMed ID: 32839463
DOI: 10.1038/s41467-020-17880-4
|
|
20122
Hendaoui I, Lahmar A, Campo L, Mebarki S, Bichet S, Hess D, Degen M, Kchir N, Charrada-Ben Farhat L, Hefaiedh R, Ruiz C, Terracciano LM, Tucker RP, Hendaoui L, Chiquet-Ehrismann R.
Tenascin-W Is a Novel Stromal Marker in Biliary Tract Cancers.
Front Immunol
2020
11:630139
PubMed ID: 33692777
DOI: 10.3389/fimmu.2020.630139
|
|
11395
Subbannayya T, Leal-Rojas P, Zhavoronkov A, Ozerov IV, Korzinkin M, Babu N, Radhakrishnan A, Chavan S, Raja R, Pinto SM, Patil AH, Barbhuiya MA, Kumar P, Guerrero-Preston R, Navani S, Tiwari PK, Kumar RV, Prasad TSK, Roa JC, Pandey A, Sidransky D, Gowda H, Izumchenko E, Chatterjee A.
PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40).
J Cell Commun Signal
2019
PubMed ID: 30666556
DOI: 10.1007/s12079-018-00503-5
|
|
3726
Kirti Gondkar, Krishna Patel, Geeta V. Patil Okaly, Bipin Nair, Akhilesh Pandey, Harsha Gowda and Prashant Kumar
Dickkopf Homolog 3 (DKK3) Acts as a Potential Tumor Suppressor in Gallbladder Cancer
Front Oncol
2019
9:1121
PubMed ID: 31737564
DOI: 10.3389/fonc.2019.01121
|
|
3738
Yamashita-Kashima Y, Yoshimura Y, Fujimura T, Shu S, Yanagisawa M, Yorozu K, Furugaki K, Higuchi R, Shoda J, Harada N.
Molecular targeting of HER2-overexpressing biliary tract cancer cells with trastuzumab emtansine, an antibody-cytotoxic drug conjugate.
Cancer Chemother Pharmacol.
2019
83(4):659-671
PubMed ID: 30659304
DOI: 10.1007/s00280-019-03768-8
|
|
3730
Gamo K, Okuzono Y, Yabuki M, Ochi T, Sugimura K, Sato Y, Sagara M, Hayashi H, Ishimura Y, Nishimoto Y, Murakawa Y, Shiokawa Z, Gotoh M, Miyazaki T, Ebisuno Y.
Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease.
Inflamm Bowel Dis
2018
24(6):1251-1265
PubMed ID: 29669006
DOI: 10.1093/ibd/izy079
|
|
10170
Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, García P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corvalán AH, Grez M, Pandey A, Leal-Rojas P, Roa JC.
Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.
Oncotarget
2017
8:26169-26184
PubMed ID: 28412732
DOI: 10.18632/oncotarget.15410
|
|
10222
Yang L, Huang S, Ma H, Wu X, Feng F.
MicroRNA-125b predicts clinical outcome and suppressed tumor proliferation and migration in human gallbladder cancer.
Tumour Biol.
2017
39:1010428317692249
PubMed ID: 28347246
DOI: 10.1177/1010428317692249
|
|
3690
uchegger K, Silva R2, López J1, Ili C1, Araya JC3, Leal P2, Brebi P1, Riquelme I4, Roa JC5.
The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
Pathol Res Pract.
2017
213(5):476-482
PubMed ID: 28285962
DOI: 10.1016/j.prp.2017.01.025
|
|
3725
Kawamoto M, Onishi H, Ozono K, Yamasaki A, Imaizumi A, Kamakura S, Nakano K, Oda Y, Sumimoto H, Nakamura M
Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancer.
Oncotarget
2017
8(22):36211-36224
PubMed ID: 28423707
DOI: 10.18632/oncotarget.16063
|
|
3727
Yeung Y, Lau DK, Chionh F, Tran H, Tse JWT, Weickhardt AJ, Nikfarjam M, Scott AM, Tebbutt NC, Mariadason JM
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines.
Mol Oncol
2017
11(9):1130-1142
PubMed ID: 28544747
DOI: 10.1002/1878-0261.12078
|
|
3728
Makoto Kawamoto, Hideya Onishi, Keigo Ozono, Akio Yamasaki, Akira Imaizumi and Masafumi Nakamura
TrkB-mediated signaling contributes to malignant phenotypes of gallbladder cancer
Cancer Research
2017
1-5
DOI: 10.1158/1538-7445.AM2017-5794
|
|
3731
Mittal B, Yadav S.
Targeting the hedgehog pathway for gallbladder cancer therapy?
Chin Clin Oncol
2016
5(1):2
PubMed ID: 26932426
DOI: 10.3978/j.issn.2304-3865.2015.12.03
|
|
3691
Weber H, Leal P, Stein S, Kunkel H, García P, Bizama C, Espinoza JA, Riquelme I, Nervi B, Araya JC, Grez M, Roa JC.
Rapamycin and WYE-354 suppress human gallbladder cancer xenografts in mice.
Oncotarget
2015
6(31):31877-88
PubMed ID: 26397134
DOI: 10.18632/oncotarget.5047
|
|
3709
Kawamoto T, Ishige K, Thomas M, Yamashita-Kashima Y, Shu S, Ishikura N, Ariizumi S, Yamamoto M, Kurosaki K, Shoda J.
Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
J Gastroenterol
2015
50(4):467-79
PubMed ID: 25112701
DOI: 10.1007/s00535-014-0984-5
|
|
3729
Subbannayya T et al
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
BMC Cancer
2015
15:843
PubMed ID: 26530123
DOI: 10.1186/s12885-015-1855-z
|
|
17464
Shi Z, Huang Q, Chen J, Yu P, Wang X, Qiu H, Chen Y, Dong Y.
Correlation of HMGB1 expression to progression and poor prognosis of adenocarcinoma and squamous cell/adenosquamous carcinoma of gallbladder
Am J Transl Res
2015
7(10):2015-25
PubMed ID: 26692945
|
|
13739
Letelier P, García P, Leal P, Álvarez H, Ili C, López J, Castillo J, Brebi P, Roa JC.
miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer
Int J Clin Exp Pathol
2014
7(5):1849-67
PubMed ID: 24966896
|
|
14930
Takahashi N, Aoyama F, Hiyoshi M, Kataoka H, Sawaguchi A.
Establishment and biological characterization of a novel cell line derived from hepatoid adenocarcinoma originated at the ampulla of Vater
Int J Oncol
2014
44(4):1139-45
PubMed ID: 24481592
DOI: 10.3892/ijo.2014.2282
|
|
3693
Leal P, Garcia P, Sandoval A, Buchegger K, Weber H, Tapia O, Roa JC.
AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines.
Onco Targets Ther
2013
6:1373-84
PubMed ID: 24124380
DOI: 10.2147/OTT.S46897
|
|
3694
Yang S, Lee KT, Lee JY, Lee JK, Lee KH, Rhee JC.
Inhibition of SCAMP1 suppresses cell migration and invasion in human pancreatic and gallbladder cancer cells.
Tumour Biol
2013
34(5):2731-9
PubMed ID: 23653380
DOI: 10.1007/s13277-013-0825-9
|
|
3714
Kato N, Yamamoto H, Adachi Y, Ohashi H, Taniguchi H, Suzuki H, Nakazawa M, Kaneto H, Sasaki S, Imai K, Shinomura Y.
Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
World J Gastroenterol
2013
19(11):1718-27
PubMed ID: 23555160
DOI: 10.3748/wjg.v19.i11.1718
|
|
19025
Sekine S, Shimada Y, Nagata T, Moriyama M, Omura T, Yoshioka I, Hori R, Matsui K, Sawada S, Okumura T, Yoshida T, Tsukada K.
Establishment and characterization of a new human gallbladder carcinoma cell line
Anticancer Res
2012
32(8):3211-8
PubMed ID: 22843894
|
|
3722
Ohashi H, Adachi Y, Yamamoto H, Taniguchi H, Nosho K, Suzuki H, Arimura Y, Imai K, Carbone DP, Shinomura Y.
Insulin-like growth factor receptor expression is associated with aggressive phenotypes and has therapeutic activity in biliary tract cancers.
Cancer Sci
2012
103(2):252-61
PubMed ID: 22044563
DOI: 10.1111/j.1349-7006.2011.02138.x
|
|
6101
Ono H, Hiraoka N, Lee YS, Woo SM, Lee WJ, Choi IJ, Saito A, Yanagihara K, Kanai Y, Ohnami S, Chiwaki F, Sasaki H, Sakamoto H, Yoshida T, Saeki N.
Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis.
Genes Chromosomes Cancer.
2012
51(1):30-41
PubMed ID: 21936014
DOI: 10.1002/gcc.20928
|
|
6319
Wu LC, Chen LT, Tsai YJ, Lin CM, Lin CY, Tian YF, Sheu MJ, Uen YH, Shiue YL, Wang YH, Yang SJ, Wu WR, Li SH, Iwamuro M, Kobayasshi N, Huang HY, Li CF.
Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator.
J Clin Pathol
2012
65(4):309-14
PubMed ID: 22267983
DOI: 10.1136/jclinpath-2011-200489
|
|
16078
Yang MH, Lee KT, Yang S, Lee JK, Lee KH, Moon IH, Rhee JC.
Guggulsterone enhances antitumor activity of gemcitabine in gallbladder cancer cells through suppression of NF-κB
J Cancer Res Clin Oncol
2012
138(10):1743-51
PubMed ID: 22699931
DOI: 10.1007/s00432-012-1254-7
|
|
7862
Sato J, Kimura T, Saito T, Anazawa T, Kenjo A, Sato Y, Tsuchiya T, Gotoh M.
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.
J Hepatobiliary Pancreat Sci
2011
18:700-11
PubMed ID: 21451941
DOI: 10.1007/s00534-011-0376-7
|
|
19029
Kanamori-Katayama M, Kaiho A, Ishizu Y, Okamura-Oho Y, Hino O, Abe M, Kishimoto T, Sekihara H, Nakamura Y, Suzuki H, Forrest AR, Hayashizaki Y.
LRRN4 and UPK3B are markers of primary mesothelial cells
PLoS One
2011
6(10):e25391
PubMed ID: 21984916
DOI: 10.1371/journal.pone.0025391
|
|
3711
Fukushima T, Kawaguchi M, Yamasaki M, Tanaka H, Yorita K, Kataoka H.
Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells.
Cancer Sci
2011
102(2):407-13
PubMed ID: 21166957
DOI: 10.1111/j.1349-7006.2010.01808.x
|
|
8464
Yamaguchi J, Sasaki M, Sato Y, Itatsu K, Harada K, Zen Y, Ikeda H, Nimura Y, Nagino M, Nakanuma Y.
Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma.
Cancer Sci.
2010
101:355-62
PubMed ID: 19860841
DOI: 10.1111/j.1349-7006.2009.01387.x
|
|
8548
Yamaguchi J, Sasaki M, Harada K, Zen Y, Sato Y, Ikeda H, Itatsu K, Yokoyama Y, Ando H, Ohta T, Kubota A, Shimizu K, Nimura Y, Nagino M, Nakanuma Y.
Papillary hyperplasia of the gallbladder in pancreaticobiliary maljunction represents a senescence-related lesion induced by lysolecithin.
Lab. Invest.
2009
89:1018-31
PubMed ID: 19564843
DOI: 10.1038/labinvest.2009.65
|
|
3705
Oka T, Yamamoto H, Sasaki S, Ii M, Hizaki K, Taniguchi H, Adachi Y, Imai K, Shinomura Y.
Overexpression of beta3/gamma2 chains of laminin-5 and MMP7 in biliary cancer.
World J Gastroenterol
2009
15(31):3865-73
PubMed ID: 19701966
DOI: 10.3748/wjg.15.3865
|
|
18693
Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, Hirohashi S.
Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer
Gastroenterology
2008
135(4):1358-1368
PubMed ID: 18692501
DOI: 10.1053/j.gastro.2008.06.082
|
|
3712
Maehata T, Taniguchi H, Yamamoto H, Nosho K, Adachi Y, Miyamoto N, Miyamoto C, Akutsu N, Yamaoka S, Itoh F.
Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer.
World J Gastroenterol
2008
14(17):2702-14
PubMed ID: 18461655
DOI: 10.3748/wjg.14.2702
|
|
19308
Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, Shinomura Y.
Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer
J Pathol
2007
213(2):131-9
PubMed ID: 17724792
DOI: 10.1002/path.2216
|
|
19219
Sato K, Kitajima Y, Koga Y, Miyazaki K.
The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells
Anticancer Res
2005
25(6B):4021-8
PubMed ID: 16309194
|
|
3701
DINGAng TONGSaixiong SUOTao
Relations of hTERT and β-Catenin Expression with Cell Growth and Invasion in Gallbladder Cell Line
Clinical Medical Journal of China
2005
|
|
3713
Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Oncogene
2005
24(53):7946-52
PubMed ID: 16007117
DOI: 10.1038/sj.onc.1208910
|
|
13744
Sato K, Kitajima Y, Kohya N, Miyoshi A, Koga Y, Miyazaki K.
Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest
Int J Oncol
2005
26(6):1653-61
PubMed ID: 15870882
|
|
3717
Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T.
Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Oncogene
2004
23(13):2401-7
PubMed ID: 14743205
DOI: 10.1038/sj.onc.1207395
|
|
3699
Nakano K, Todo T, Chijiiwa K, Tanaka M.
Therapeutic efficacy of G207, a conditionally replicating herpes simplex virus type 1 mutant, for gallbladder carcinoma in immunocompetent hamsters.
Mol Ther
2001
3(4):431-7.
PubMed ID: 11319903
DOI: 10.1006/mthe.2001.0303
|
戻る
細胞材料の再培養方法 (
HPS以外・
HPS )
ページトップへ
細胞材料開発室サイト
